PDI receives new contract sales engagement; expects $10 to $12 million revenue in 2010

PDI, Inc. (Nasdaq: PDII), a leading provider of sales and marketing support to U.S. health care companies, has been awarded a new contract sales engagement with a Top 10 pharmaceutical company that is expected to generate approximately $10 to $12 million in revenue in 2010.

"We have now announced two significant new business wins and a major contract renewal during the past three weeks," said Nancy Lurker, Chief Executive Officer of PDI, Inc. "These new and renewed transactions demonstrate the high impact and return on investment that PDI continues to provide to our existing and new clients. As a company, we continually strive to provide added value and increased benefit in all of our offerings and it is encouraging to see the results of this focus, especially when it leads to new business wins."

The new contract covers an assignment in the primary care area, utilizing PDI's Shared Sales solution, formerly known as Select Access. Sales representatives are expected in the field in February 2010.

"This new engagement, coupled with other significant new contracts secured in 2009, allows us to enter 2010 with confidence and optimism," noted Lurker. "In June we announced several new business wins and our representatives are now actively involved with these engagements."